Ovid Therapeutics (OVID) - 2022 Q2 - Quarterly Report
Ovid Therapeutics (OVID)2022-08-09 12:21Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) Ovid Therapeutics Inc. (Exact Name of Registrant as Specified in its Charter) _______________________________________________________ Delaware 46-5270895 (State or Other Jurisdiction of Incorporation or Organization) 441 Ninth Avenue, 14th Floor New York, New York 10001 (Address of principa ...